drugset / Trial / NCT01269684
Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate safety and tolerability of an immediate conversion from Tacrolimus to everolimus in stable renal allograft recipients. Interest in developing CNI-free regimens using other agents such as the proliferation signal inhibitor everolimus.
Timeline
- Start
- 2008-08
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | 1.5 mg | — |
Indications
No indication recorded.